-+ 0.00%
-+ 0.00%
-+ 0.00%

ARROWHEAD PHARMACEUTICALS INITIATES PHASE 1/2A STUDY OF ARO-MAPT FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND OTHER TAUOPATHIES

Reuters·12/08/2025 12:30:00

Please log in to view news